openPR Logo
Press release

Ulcerative Colitis Therapeutics Market to Expand 1.4X and Reach Valuation of US$ 7.9 Bn by 2027: Fact.MR

10-10-2022 01:50 PM CET | Health & Medicine

Press release from: Fact.MR

Ulcerative Colitis Therapeutics Market to Expand 1.4X and Reach

Fact.MR, a market research and competitive intelligence provider, has conducted a comprehensive analysis on the global ulcerative colitis therapeutics market, which is expected to rise at a CAGR of 5.1% over the forecast period (2021 to 2027).

The specific cause of ulcerative colitis is unknown; however genetic causes, environmental changes, or immune system failure are all possibilities. Simple healthy practices such as having short meals throughout the day, staying hydrated, avoiding greasy foods, and reducing high-fiber food intake can help prevent ulcerative colitis.

Read Report Overview:

https://www.factmr.com/report/ulcerative-colitis-therapeutics-market

Key Takeaways from Market Study

• Global ulcerative colitis therapeutics market to reach US$ 19.9 Bn by 2027.
• Ulcerative proctitis segment is projected to reach around US$ 2.1 Bn by 2027.
• Market in Europe to record 4.2% CAGR over the forecast period of 2021-2027.
• Market in China forecast to reach US$ 1.4 Bn valuation by 2027.

"Increasing product releases & approvals, rise in active clinical studies, and growing research & development activities for the treatment of ulcerative colitis illness are likely to fuel market growth over the coming years," says a Fact.MR analyst

Get Sample PDF of This Research Report with Detailed Table of Content:

https://www.factmr.com/connectus/sample?flag=S&rep_id=7286

Winning Strategy

Key market players are focusing on the development of novel treatments for severe conditions of ulcerative colitis. Companies are involved in the development of novel drugs for the treatment of ulcerative colitis.

To enter into new markets and obtain high market share, key firms are focusing their efforts on product expansions and the development of innovative therapies, particularly in emerging economies. Alliances are being formed regularly to diversify product portfolios and boost market share.

Therapy for ulcerative colitis has two basic objectives. The first is to reduce symptom severity and improve patient comfort, while also promoting gut repair. The second goal is to prevent further flare-ups. The goal of treatment is to reduce and control the disease's indications and symptoms.

The global ulcerative colitis therapeutics market is primarily driven by an increase in the incidence of inflammatory bowel diseases, increase in ulcerative colitis cases, and development of ulcerative colitis-specific medications by a large number of key companies.

For instance,
• In 2019, Abbvie Company finalized the acquisition of Allergan, allowing it to expand its pharmaceutical range and provide patients with more advanced therapies. Allergen created a monoclonal antibody known as brazikumab, which is used to treat ulcerative colitis and Crohn's disease.
• In April 2021, Arena Pharmaceuticals, Inc. started a phase II clinical trial to see if oral etrasimod is an effective therapy for adults with moderately active ulcerative colitis.

Speak to Analyst:

https://www.factmr.com/connectus/sample?flag=AE&rep_id=7286

Competitive Landscape

The market for ulcerative colitis therapeutics is highly competitive. Certain strategic efforts, such as mergers, new product launches, acquisitions, and collaborations, are implemented by key players to help them increase their market position.

For instance :
• In May 2021, The U.S. Food and Drug Administration (FDA) approved Bristol Myers Squibb's Zeposia (ozanimod) for the treatment of individuals with moderately to highly active ulcerative colitis (UC), a chronic inflammatory bowel disease (IBD).

Key Segments Covered in Ulcerative Colitis Therapeutics Industry Research

• Ulcerative Colitis Therapeutics Market by Disease Type :
o Ulcerative Proctitis
o Proctosigmoiditis
o Left-sided Colitis
o Pancolitis or Universal Colitis
o Fulminant Colitis

• Ulcerative Colitis Therapeutics Market by Route of Administration :
o Oral
o Injectables

• Ulcerative Colitis Therapeutics Market by
Region :
o North America Ulcerative Colitis Therapeutics Market
o Europe Ulcerative Colitis Therapeutics Market
o Asia Pacific Ulcerative Colitis Therapeutics Market
o Latin America Ulcerative Colitis Therapeutics Market
o MEA Ulcerative Colitis Therapeutics Market

Choose Quick and Secure PayPal Payment Mode to Get Full Access to This Report:

https://www.factmr.com/checkout/7286

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Market research and consulting agency with a difference! That's why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range - from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we'll be an able research partner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ulcerative Colitis Therapeutics Market to Expand 1.4X and Reach Valuation of US$ 7.9 Bn by 2027: Fact.MR here

News-ID: 2762293 • Views:

More Releases from Fact.MR

Fine Blanking Tools Market Projected to Reach USD 1.43 Billion by 2035 | U.S. CAGR at a 5.3%
Fine Blanking Tools Market Projected to Reach USD 1.43 Billion by 2035 | U.S. CA …
The global Fine Blanking Tools Market is set for steady growth over the next decade, driven by rising demand for high-precision components, ongoing industrial automation, and surging requirements from automotive, electronics, and aerospace sectors. According to a recent forecast, the market is expected to grow from approximately USD 948.1 million in 2025 to USD 1,430.6 million by 2035, at a compound annual growth rate (CAGR) of about 4.2 % between
Benzodiazepine Drugs Market is Expanding USD 5.4 billion by 2035 | Pfizer Inc.; Akorn Inc; Hikma; Hameln Pharmaceutical; Accord; Others.
10-08-2025 | Health & Medicine
Fact.MR
Benzodiazepine Drugs Market is Expanding USD 5.4 billion by 2035 | Pfizer Inc.; …
The global benzodiazepine drugs market is projected to expand in the coming decade, driven by growing incidence of anxiety, insomnia, alcohol-withdrawal disorders, and advances in pharmaceutical formulations. According to a recent Fact.MR report, the market was valued at approximately USD 2.35 billion in 2022, and is expected to grow at a compound annual growth rate (CAGR) of 2.8% to reach USD 3.1 billion by 2032. Market Drivers & Outlook The demand for
Ultrasound Systems Market to Surge to Nearly USD 20 Billion by 2035, Led by Advances in 2D, Cart-Based Systems & AI-Enabled Portability
10-08-2025 | Health & Medicine
Fact.MR
Ultrasound Systems Market to Surge to Nearly USD 20 Billion by 2035, Led by Adva …
The global Ultrasound Systems Market is on a strong growth trajectory, projected to rise from USD 10.8 billion in 2025 to approximately USD 19.7 billion by 2035, expanding at a CAGR of 6.2% during the forecast period. This growth is fueled by the rising demand for non-invasive diagnostic imaging, the increasing prevalence of chronic diseases, expanding healthcare infrastructure, and continuous technological innovations such as AI integration and portable imaging systems. Key
Surgical Staplers Market Is Forecasted To Reach USD 6.0 Billion In 2025 | Ethicon US LLC, Cardica Inc., Smith & Nephew Plc, CONMED Corporation., Purple Surgical Inc., Dextera Surgical Inc, and Others.
10-08-2025 | Health & Medicine
Fact.MR
Surgical Staplers Market Is Forecasted To Reach USD 6.0 Billion In 2025 | Ethico …
The global Surgical Staplers Market is forecast to show strong growth over the next decade, nearly doubling in value as demand surges for efficient, reliable wound closure in advanced surgical procedures. According to the latest Fact.MR Surgical Staplers Market Size & Share Forecast Outlook 2025-2035 report, the market is expected to grow from USD 6.0 billion in 2025 to USD 12.5 billion by 2035, at a compound annual growth rate

All 5 Releases


More Releases for Colitis

Ulcerative Colitis Pipeline Insights Report | DelveInsight
DelveInsight's, "Ulcerative Colitis Pipeline Insight" report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Ulcerative Colitis Pipeline Landscape. It covers the Ulcerative Colitis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Ulcerative Colitis therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight and stay
Novel Therapies for Ulcerative Colitis Patients
"The Business Research Company recently released a comprehensive report on the Global Ulcerative Colitis Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The ulcerative colitis market size
Ulcerative Colitis Market - Breaking Barriers, Transforming Digestive Health: Ul …
Newark, New Castle, USA: The "Ulcerative Colitis Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Ulcerative Colitis Market: https://www.growthplusreports.com/report/ulcerative-colitis-market/8815 This latest report researches the industry structure, sales, revenue,
Ulcerative Colitis Market - Breaking Barriers, Empowering Resilience: Transformi …
Newark, New Castle, USA - new report, titled Ulcerative Colitis Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Ulcerative Colitis market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Ulcerative Colitis market. The report offers an overview of the market, which
Ulcerative Colitis - Drug Pipeline Landscape, 2023
Global Ulcerative Colitis Market report from Global Insight Services is the single authoritative source of intelligence on ulcerative colitis market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types,
Ulcerative Colitis Market
Ulcerative colitis is the most common type of inflammatory bowel disease that affects the colon (lining of the large intestine) and rectum. The inflammation produces tiny sores called ulcers. These disease can affect people of any age, though prevalence is especially high among people under 30 years of age. The major symptoms of this disease are diarrhea, belly pain/cramps, bleeding from the rectum, also other indications are sudden and unexplained